Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Health and Quality of Life Outcomes
|
January 29, 2005
Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus)
Linda E Carlson, Barry D Bultz, Donald G Morris
Plos One
|
May 12, 2017
Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer
Ayan Chanda, Angela Chan, Lili Deng, et al.
Clinical Lymphoma
|
October 15, 2003
Lymphomas and oncolytic virus therapy
Tommy Alain, Chandini Thirukkumaran, Donald G Morris, et al.
Blood
|
February 10, 2006
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
Douglas A Stewart, Nizar Bahlis, Karen Valentine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2016
Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
Keith A Lawson, Ahmed A Mostafa, Zhong Qiao Shi, et al.
Blood
|
March 15, 2003
Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation
Chandini M Thirukkumaran, Joanne M Luider, Douglas A Stewart, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 4, 2022
The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada
Darren R Brenner, Dylan E O'Sullivan, Tamer N Jarada, et al.
Health Physics
|
June 12, 2008
Data collection, processing, validation, and verification
Deborah L Martin, Jennifer L Hoff, Roger A Gard, et al.
The Journal of Pathology. Clinical Research
|
May 12, 2020
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma
Angela My Chan, Emeka Enwere, John B McIntyre, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy
Penelope A Bradbury, Donald G Morris, Garth Nicholas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Health and Quality of Life Outcomes
|
January 29, 2005
Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus)
Linda E Carlson, Barry D Bultz, Donald G Morris
Plos One
|
May 12, 2017
Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer
Ayan Chanda, Angela Chan, Lili Deng, et al.
Clinical Lymphoma
|
October 15, 2003
Lymphomas and oncolytic virus therapy
Tommy Alain, Chandini Thirukkumaran, Donald G Morris, et al.
Blood
|
February 10, 2006
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
Douglas A Stewart, Nizar Bahlis, Karen Valentine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2016
Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma
Keith A Lawson, Ahmed A Mostafa, Zhong Qiao Shi, et al.
Blood
|
March 15, 2003
Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation
Chandini M Thirukkumaran, Joanne M Luider, Douglas A Stewart, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 4, 2022
The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada
Darren R Brenner, Dylan E O'Sullivan, Tamer N Jarada, et al.
Health Physics
|
June 12, 2008
Data collection, processing, validation, and verification
Deborah L Martin, Jennifer L Hoff, Roger A Gard, et al.
The Journal of Pathology. Clinical Research
|
May 12, 2020
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma
Angela My Chan, Emeka Enwere, John B McIntyre, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy
Penelope A Bradbury, Donald G Morris, Garth Nicholas, et al.
Page
of 1